{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:01:53Z","timestamp":1787666513239,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.amepre.2011.09.007","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T17:57:16Z","timestamp":1321552636000},"page":"S376-S383","source":"Crossref","is-referenced-by-count":51,"special_numbering":"S4","title":["Sickle Cell Disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Hussain R.","family":"Yusuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"Lloyd-Puryear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Althea M.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa S.","family":"Creary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani K.","family":"Atrash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2011.09.007_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.amepre.2011.09.007_bib2","first-page":"704","article-title":"Inherited haemoglobin disorders: an increasing global health problem","volume":"79","author":"Weatherall","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.amepre.2011.09.007_bib3","series-title":"Sickle cell disease: screening, diagnosis, management, and counseling in newborns and infants","year":"1993"},{"key":"10.1016\/j.amepre.2011.09.007_bib4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N Eng J Med"},{"key":"10.1016\/j.amepre.2011.09.007_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0031-3955(05)70426-0","article-title":"Sickle cell disease","volume":"43","author":"Lane","year":"1996","journal-title":"Pediatr Clin N Am"},{"key":"10.1016\/j.amepre.2011.09.007_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjmed.2008.12.020","article-title":"Complications associated with sickle cell trait: a brief narrative review","volume":"122","author":"Tsaras","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.amepre.2011.09.007_bib7","first-page":"300","article-title":"Sickle cell trait and sudden death\u2014bringing it home","volume":"99","author":"Mitchell","year":"2007","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.amepre.2011.09.007_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/10245330701255254","article-title":"Exertional rhabdomyolysis and renal failure in patients with sickle cell trait: is it time to change our approach?","volume":"12","author":"Makaryus","year":"2007","journal-title":"Hematology"},{"key":"10.1016\/j.amepre.2011.09.007_bib10","series-title":"Genetics and public health in the 21st century: using public genetic information to improve health and prevent disease","article-title":"Newborn screening for sickle cell disease: public health impact and evaluation","author":"Olney","year":"2000"},{"key":"10.1016\/j.amepre.2011.09.007_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpeds.2008.06.039","article-title":"Newborn sickle cell screening in a region of Western New York State","volume":"154","author":"Lerner","year":"2009","journal-title":"J Pediatr"},{"issue":"5 Pt 2","key":"10.1016\/j.amepre.2011.09.007_bib12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1542\/peds.83.5.858","article-title":"Georgia's experience with newborn screening: 1981 to 1985","volume":"83","author":"Harris","year":"1989","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2011.09.007_bib13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1542\/peds.83.5.864","article-title":"Experiences with sickle hemoglobin testing in the Texas Newborn Screening Program","volume":"83","author":"Therrell","year":"1989","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2011.09.007_bib14","series-title":"Ethics and newborn genetic testing - new technologies, new challenges","article-title":"The role of the federal government in supporting state newborn screening programs","author":"Lloyd-Puryear","year":"2009"},{"issue":"4S","key":"10.1016\/j.amepre.2011.09.007_bib15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mpd.2000.109437","article-title":"U.S. newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation","volume":"137","author":"Pass","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.amepre.2011.09.007_bib16","series-title":"The management of sickle cell disease","year":"2002"},{"key":"10.1016\/j.amepre.2011.09.007_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajmg.c.30160","article-title":"Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states","volume":"148C","author":"Kavanagh","year":"2008","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"5 Pt 2","key":"10.1016\/j.amepre.2011.09.007_bib18","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1542\/peds.2005-2633C","article-title":"Status of newborn screening programs in the United States","volume":"117","author":"Therrell","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2011.09.007_bib19","first-page":"9","article-title":"Newborn screening coupled with comprehensive follow-up reduced early mortality of sickle cell disease in Connecticut","volume":"71","author":"Frempong","year":"2007","journal-title":"Conn Med"},{"key":"10.1016\/j.amepre.2011.09.007_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1258\/096914107782066185","article-title":"Newborn sickle cell disease screening: the Jamaican experience (1995\u20132006)","volume":"14","author":"King","year":"2007","journal-title":"J Med Screen"},{"key":"10.1016\/j.amepre.2011.09.007_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1081\/HEM-120015024","article-title":"Decreased morbidity in homozygous sickle cell disease detected at birth","volume":"26","author":"Bardakdjian-Michau","year":"2002","journal-title":"Hemoglobin"},{"key":"10.1016\/j.amepre.2011.09.007_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jcp.2008.059113","article-title":"Newborn screening for sickle cell disease in the Republic of Benin","volume":"62;","author":"Rahimy","year":"2009","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.amepre.2011.09.007_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle-cell disease in the United States: national and state estimates","volume":"85","author":"Brousseau","year":"2010","journal-title":"Am J Hematol"},{"issue":"4S","key":"10.1016\/j.amepre.2011.09.007_bib24","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S.","volume":"38","author":"Hassel","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2011.09.007_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/(SICI)1098-2272(1996)13:5<501::AID-GEPI6>3.0.CO;2-4","article-title":"Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state","volume":"13","author":"Lorey","year":"1996","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.amepre.2011.09.007_bib26","first-page":"1012","article-title":"Impact of expanded newborn screening\u2014United States, 2006","volume":"57","author":"Therrell","year":"2008","journal-title":"MMWR"},{"key":"10.1016\/j.amepre.2011.09.007_bib27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776","article-title":"Clinical events in the first decade in a cohort of infants with sickle cell disease","volume":"86","author":"Gill","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.amepre.2011.09.007_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1067\/S0022-3476(03)00466-9","article-title":"Prevention of invasive pneumococcal infection in sickle cell disease: on the threshold of a new era of successes?","volume":"143","author":"Overturf","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.amepre.2011.09.007_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.84.3.500","article-title":"Mortality in children and adolescents with sickle cell disease","volume":"84","author":"Leikin","year":"1989","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.amepre.2011.09.007_bib30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/clinids\/14.5.1124","article-title":"Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanism, prophylaxis, and vaccination","volume":"14","author":"Wong","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amepre.2011.09.007_bib31","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jama.1981.03310430031017","article-title":"Pneumococcal septicemia in children with sickle cell anemia","volume":"245","author":"Powars","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2011.09.007_bib32","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia","volume":"314","author":"Gaston","year":"1986","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amepre.2011.09.007_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0022-3476(86)80216-5","article-title":"Bacteremia in sickle hemoglobinopathies","volume":"109","author":"Zarkowski","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.amepre.2011.09.007_bib34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0022-3476(05)80036-8","article-title":"Experience with the use of prophylactic penicillin in children with sickle cell anemia","volume":"118","author":"Pegelow","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.amepre.2011.09.007_bib35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1542\/peds.2007-0018","article-title":"Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life","volume":"121","author":"Adamkiewicz","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2011.09.007_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpeds.2008.09.052","article-title":"Trends in pediatric sickle cell disease-related mortality in the United States, 1983\u20132002","volume":"154","author":"Yanni","year":"2008","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.amepre.2011.09.007_bib37","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1542\/peds.70.6.926","article-title":"Oral penicillin prophylaxis in children with impaired splenic function: a study of compliance","volume":"70","author":"Buchanan","year":"1982","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2011.09.007_bib38","first-page":"428","article-title":"Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia","volume":"140","author":"Buchanan","year":"1986","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1016\/j.amepre.2011.09.007_bib39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/S0022-3476(03)00331-7","article-title":"Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination","volume":"143","author":"Adamkiewicz","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.amepre.2011.09.007_bib40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00043426-200102000-00009","article-title":"Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease","volume":"23","author":"Elliot","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"issue":"S2","key":"10.1016\/j.amepre.2011.09.007_bib41","first-page":"S14","article-title":"Toward evidence-based quality improvement","volume":"21","author":"Grimshaw","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amepre.2011.09.007_bib42","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0027-9684(15)31069-5","article-title":"A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease","volume":"101","author":"Haywood","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.amepre.2011.09.007_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0882-5963(99)80028-1","article-title":"Current knowledge in the management of children and adolescents with sickle cell disease: part 1, physiological issues","volume":"14","author":"Simon","year":"1999","journal-title":"J Pediatr Nurs"},{"issue":"S2","key":"10.1016\/j.amepre.2011.09.007_bib44","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0268-960X(08)70004-3","article-title":"Cardiac iron across different transfusion-dependent diseases","volume":"22","author":"Wood","year":"2008","journal-title":"Blood Rev"},{"key":"10.1016\/j.amepre.2011.09.007_bib45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ajh.21100","article-title":"Concepts and goals in the management of transfusional iron overload","volume":"82","author":"Porter","year":"2007","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.amepre.2011.09.007_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MPH.0b013e3181b53363","article-title":"Adherence to deferasirox in children and adolescents with sickle cell disease during 1-year of therapy","volume":"31","author":"Alvarez","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.amepre.2011.09.007_bib47","series-title":"Sickle cell disease patients in U.S. hospitals, 2004","author":"Steiner","year":"2006"},{"key":"10.1016\/j.amepre.2011.09.007_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajh.21569","article-title":"Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease","volume":"85","author":"Fitzhugh","year":"2010","journal-title":"Am. J. Hematol"},{"key":"10.1016\/j.amepre.2011.09.007_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pedn.2006.09.001","article-title":"Events of hospitalization among children with sickle cell disease","volume":"22","author":"Fosdal","year":"2007","journal-title":"J Pediatr Nurs"},{"issue":"4S","key":"10.1016\/j.amepre.2011.09.007_bib50","doi-asserted-by":"crossref","first-page":"S536","DOI":"10.1016\/j.amepre.2010.01.001","article-title":"Emergency department visits made by patients with sickle cell disease: a descriptive study","volume":"38","author":"Yusuf","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2011.09.007_bib51","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database","volume":"85","author":"Lanzkron","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amepre.2011.09.007_bib52","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0027-9684(15)31069-5","article-title":"A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease","volume":"101","author":"Haywood","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.amepre.2011.09.007_bib53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.21315","article-title":"Sickle cell disease summit: from clinical and research disparity to action","volume":"84","author":"Hassell","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amepre.2011.09.007_bib54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ajh.21750","article-title":"Utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: effect of sex, age, and geographical location","volume":"85","author":"Ballas","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amepre.2011.09.007_bib55","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3324\/haematol.11213","article-title":"Asthma is associated with increased mortality in individuals with sickle cell anemia","volume":"92","author":"Boyd","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.amepre.2011.09.007_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/asheducation-2009.1.45","article-title":"Asthma and sickle cell disease: two distinct diseases or part of the same process?","author":"Field","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.amepre.2011.09.007_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1537-2995.2007.01484.x","article-title":"Blood transfusions in children: a multi-institutional analysis of practices and complications","volume":"48","author":"Slonim","year":"2008","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.amepre.2011.09.007_bib58","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/blood-2004-02-0636","article-title":"Declining stroke rates in Californian children with sickle cell disease","volume":"104","author":"Fullerton","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.amepre.2011.09.007_bib59","first-page":"1013","article-title":"Sickle cell disease in childhood: part I","volume":"62","author":"Wethers","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.amepre.2011.09.007_bib60","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/jwh.2007.CDC4","article-title":"Sickle cell disease: current activities, public health implications, and future directions","volume":"16","author":"Creary","year":"2007","journal-title":"J Womens Health"},{"key":"10.1016\/j.amepre.2011.09.007_bib61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archpedi.155.2.120","article-title":"Genetic counseling and risk communication services of newborn screening programs","volume":"155","author":"Farrell","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.amepre.2011.09.007_bib62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1745-7599.2007.00254.x","article-title":"Written educational materials for families of chronically ill children","volume":"19","author":"Mahat","year":"2007","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.amepre.2011.09.007_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1542\/peds.2007-2875","article-title":"Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders","volume":"123","author":"Grosse","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2011.09.007_bib64","first-page":"886","article-title":"Patient satisfaction in specialized vs. non-specialized adult sickle cell care centers","volume":"99","author":"Aisiku","year":"2007","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.amepre.2011.09.007_bib65","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.109.3.526","article-title":"Health supervision for children with sickle cell disease","volume":"109","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2011.09.007_bib66","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/pbc.21537","article-title":"Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease","volume":"51","author":"Raphael","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.amepre.2011.09.007_bib67","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","article-title":"Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises","volume":"95","author":"Benjamin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.amepre.2011.09.007_bib68","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1353\/hpu.2010.0834","article-title":"Hospital resource utilization among patients with sickle cell disease","volume":"14","author":"Mayer","year":"2003","journal-title":"J Health Care Poor Underserved"},{"issue":"1","key":"10.1016\/j.amepre.2011.09.007_bib69","first-page":"44","article-title":"Hospital utilization patterns and costs for adult sickle cell patients in Illinois","volume":"112","author":"Woods","year":"1997","journal-title":"Public Health Rep"},{"key":"10.1016\/j.amepre.2011.09.007_bib70","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ajmg.a.31576","article-title":"Access to health insurance: experiences and attitudes of those with genetic versus non-genetic medical conditions","volume":"143","author":"Kass","year":"2007","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.amepre.2011.09.007_bib71","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.GIM.0000162874.58370.C0","article-title":"Concerns in a primary care population about genetic discrimination by insurers","volume":"7","author":"Hall","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.amepre.2011.09.007_bib72","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0029-6465(22)02514-2","article-title":"Genetic discrimination in health insurance: an overview and analysis of the issues","volume":"35","author":"Roth","year":"2000","journal-title":"Nurs Clin North Am"},{"key":"10.1016\/j.amepre.2011.09.007_bib73","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pbc.21781","article-title":"Health care utilization and expenditures for low income children with sickle cell disease","volume":"52","author":"Raphael","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.amepre.2011.09.007_bib74","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1542\/peds.108.4.906","article-title":"Who cares for Medicaid-enrolled children with chronic conditions?","volume":"108","author":"Kuhlthau","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2011.09.007_bib75","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ajh.20485","article-title":"Medical care utilization and mortality in sickle cell disease: a population-based study","volume":"80","author":"Shankar","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amepre.2011.09.007_bib76","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ajh.21749","article-title":"Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization","volume":"85","author":"Brandow","year":"2010","journal-title":"Am J Hematol"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379711006209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379711006209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T20:48:27Z","timestamp":1713127707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379711006209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0749379711006209"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2011.09.007","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}